Insider buying last 90 days
No open-market insider purchases were filed for INSP in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every INSP insider filing, plotted on the chart in Gekko.Open INSP in Gekko
NYSE: INSP
Inspire Medical Systems (INSP) Stock Analysis & Forecast
Oct 12 close
$71.49+2.60 (+3.8%)
Gekko Brief
AI summaryOct 12 closeInspire Medical Systems gained ground this week, with shares rising 3.3% to $68.89 before closing at $71.49. The company secured new Category I CPT codes for hypoglossal nerve stimulation procedures from the AMA's CPT Editorial Panel, effective January 1, 2028, following its Q2 2026 results in which management raised full-year guidance for revenue, adjusted operating margin, and adjusted EPS. Barclays initiated coverage with an Underweight rating and a $65.00 price target, while separate legal notices referenced pending shareholder claims and investigations involving the company among others.
The stock trades at $71.49, above both its 50-day average of $65.41 and 200-day average of $60.29, with the shorter average above the longer one, pointing to a supportive trend. The GekkoIndex reads 54.7, placing it in the Neutral zone. Price sits 22.4% below Gekko Fair Value of $92.11.
Earnings are scheduled for 2 November 2026 after close, 21 days away and within a typical 20-trading-day holding period; the prior quarter's reaction was 27.7% against an average absolute move of 13.7% across eight quarters, each a beat. Seasonality over the next 20 trading days has averaged 8.3% across five years, rising in four of them. No insider, Congress, or unusual options activity appears in the current window. Analyst views remain split, with 16 firms covering the name and a consensus target of $65.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Inspire Medical Systems price vs fair value
Close $71.49200-day averageGekko Fair Value $92.11
Inspire Medical Systems quick facts
- Market cap
- $2.07B
- P/E ratio
- 14.7
- Forward P/E
- 59.2
- EPS, TTM
- $4.54
- Revenue, TTM
- $898.7M
- Profit margin
- 15%
- Dividend yield
- —
- Beta
- 0.73
- Volume
- 998,596 avg 940,591
- 1-year return
- −10.8%
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±10.4%
- 50-day average
- $65.41
- 200-day average
- $60.29
- Next earnings
- Nov 2 after close
- Shares outstanding
- 28.91M
Inspire Medical Systems swing-trade checklist
Inspire Medical Systems scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $71.49 is above the 50-day ($65.41) and 200-day ($60.29) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
54.7, Neutral
Reading 54.7 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
22.4% below
Price is 22.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 21 days
Reports on Nov 2, 2026, 21 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+8.3% on average
From this point in the calendar, the next 20 trading days averaged +8.3% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Inspire Medical Systems stock chart and price history
Inspire Medical Systems closed at $71.49 on Oct 12, 2026, −10.8% over the past year, inside a 52-week range of $38.91 to $147.03.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −2.1%
- 3 months
- +45.5%
- 6 months
- +30.2%
- 1 year
- −10.8%
The full INSP chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open INSP in Gekko
Follow Inspire Medical Systems through every session
Put INSP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track INSP in GekkoFree for 7 days. No credit card required.
About Inspire Medical Systems
Inspire Medical Systems focuses on treatments for obstructive sleep apnea, offering therapies designed to be less invasive than many existing options. It serves patients in the United States as well as other countries. The company is known chiefly for its Inspire system, a neurostimulation device built for people with moderate to severe forms of the condition.
Its approach centers on a closed-loop technology that monitors a patient's breathing as it happens and delivers mild stimulation to the hypoglossal nerve to help keep the airway open. This places the company's work at the intersection of device development and ongoing patient monitoring, rather than a one-time surgical fix, with its therapies brought to both domestic and international markets.
Inspire Medical Systems was founded in 2007 and is headquartered in Golden Valley, Minnesota. Its shares are listed on the NYSE under the ticker INSP.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- inspiresleep.com
Inspire Medical Systems GekkoIndex: the smart money zone
Inspire Medical Systems’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.7, in the Neutral zone, down 0.6 points over five sessions.
54.7Neutral
Down 0.6 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 58 | −0.1% | −2.5% | ||
| Accumulation | 311 | −0.7% | −1.9% | ||
| Neutral (current zone) | 259 | +0.1% | +0.6% | ||
| Distribution | 47 | −1.0% | −7.0% | ||
| Selling | 7 | Too few readings yet | |||
Average INSP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the INSP price, zone by zone.Track INSP in Gekko
Is Inspire Medical Systems stock overvalued? Gekko Fair Value
Inspire Medical Systems trades 22.4% below Gekko Fair Value of $92.11, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Inspire Medical Systems shares are worth, recalculated every trading day.
$92.11
Gekko Fair Value, Oct 10, 2026
22.4% Undervalued
At the end of Aug 2026 the price was 36.5% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open INSP in Gekko
Inspire Medical Systems insider and Congress trading
No open-market insider purchases were filed for Inspire Medical Systems, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in INSP were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for INSP, plotted on the chart in Gekko.Open INSP in Gekko
Buybacks
Inspire Medical Systems has been buying back its own shares.
- Bought back, quarter ended Dec 31, 2025
- $50.01M
- As a share of market cap
- 2.42%
From company filings.
Inspire Medical Systems earnings: next date and track record
Inspire Medical Systems reports on Nov 2, 2026, after the close (21 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 2, 2026
Expected after the close, 21 days away
- EPS estimate
- $0.09
- Revenue estimate
- $204.3M
8 of 8reports beat the EPS estimate
±13.7%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 3, 2026 AI summary
- What they said
- Inspire Medical Systems Q2 2026 results exceeded expectations, with management raising full-year 2026 guidance for revenue, adjusted operating margin, and adjusted EPS. The company navigated coding/reimbursement challenges through customer education, with C-codes now in place and hospital/ASC reimbursement rates unchanged. CMS proposed 2027 OPPS increases of 12% for hospital outpatient ($35,414) and 15% for ASC ($31,722) reimbursement rates.
- Guidance
- Management raised full-year 2026 outlook for revenue, adjusted operating margin, and adjusted EPS following Q2 outperformance. Company is not assuming any changes to future reimbursement levels pending CMS final 2027 rates expected in November.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 3, 2026 | $0.14 est −$0.22 | $200.6M est $194.7M | +27.7% |
| May 4, 2026 | $0.10 est $0.08 | $204.6M est $200.0M | −14.9% |
| Feb 11, 2026 | $1.65 est $0.68 | $269.1M est $265.7M | −12.5% |
| Nov 3, 2025 | $0.38 est −$0.19 | $224.5M est $262.3M | +17.9% |
| Aug 4, 2025 | $0.45 est $0.20 | $217.1M est $214.5M | −30.3% |
| May 5, 2025 | $0.10 est −$0.23 | $201.3M est $227.7M | +1.3% |
| Feb 10, 2025 | $1.15 est $0.72 | $239.7M est $239.8M | +1.0% |
| Nov 4, 2024 | $0.60 est $0.06 | $203.2M est $197.6M | +4.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Inspire Medical Systems stock forecast and analyst price targets
Analysts’ average 12-month price target for Inspire Medical Systems is $65.00, −9.1% from the last close, from 16 firms rating the stock in the last 90 days.
$65.00consensus 12-month target, −9.1% from the last close
Now $71.49Avg $65.00
Low $39High $97
Each firm’s latest rating in the last 90 days: 16 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 12 | Leerink Partners | $67 | −6.3% |
| Oct 6 | Barclays | $65 | −9.1% |
| Oct 2 | Piper Sandler | $60 | −16.1% |
| Oct 1 | RBC Capital | $75 | +4.9% |
| Oct 1 | RBC Capital | $75 | +4.9% |
+0.6%average 20-day move after past Neutral readings
+8.3%average move over the next 20 trading days in the last 5 years
±4.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Inspire Medical Systems seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Inspire Medical Systems averaged +8.3% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.3% | 3 of 5 |
| Next 10 trading days | −0.8% | 3 of 5 |
| Next 15 trading days | 0.0% | 2 of 5 |
| Next 20 trading days | +8.3% | 4 of 5 |
| Next 30 trading days | +4.1% | 3 of 5 |
For scale, INSP’s typical 20-trading-day move in either direction is about 10.4%.
Inspire Medical Systems market cap and key statistics
Inspire Medical Systems’s market cap is $2.07B, with a P/E ratio of 14.7 and revenue of $898.7M over the last twelve months.
Valuation
- Market cap
- $2.07B
- P/E ratio
- 14.7
- Forward P/E
- 59.2
- EPS, TTM
- $4.54
- Gekko Fair Value
- $92.11
Trading
- Volume
- 998,596
- Avg volume, 20 days
- 940,591
- 52-week high
- $147.03
- 52-week low
- $38.91
- Shares outstanding
- 28.91M
Financials
- Revenue, TTM
- $898.7M
- Profit margin
- 15%
- Return on equity
- 18%
- Quarterly earnings growth, YoY
- +308.4%
Risk and income
- Beta
- 0.73
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±10.4%
Inspire Medical Systems stock news this week
Coverage of Inspire Medical Systems this week reads negative: 3 positive, 2 neutral and 4 negative headlines.
- Price to cash flow ratio of Inspire Medical Systems, Inc. – HAN:2DRTradingView, Oct 11
- Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100GuruFocus, Oct 9
- Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Picard Medical, Inc. (PMI), Methode Electronics, Inc. (MEI), Inspire Medical Systems, Inc. (INSP), and GRAIL, Inc. (GRAL)GlobeNewswire, Oct 9
- Inspire Medical Systems Price Target Announced at $65.00/Share by BarclaysMoomoo, Oct 8
- Barclays Initiates Inspire Medical Systems at Underweight With $65 Price TargetMoomoo, Oct 8
- INSP Initiates Coverage On Barclays -- Rating Set to UnderweightGuruFocus, Oct 7
Inspire Medical Systems peers
Inspire Medical Systems’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 18.2% above |
| ABTAbbott Laboratories | Neutral | 14.7% below |
| DHRDanaher | Neutral | 4.5% above |
| ISRGIntuitive Surgical | Neutral | 18.8% above |
| MDTMedtronic | Neutral | 22.9% below |
| SYKStryker | Accumulation | 12.6% below |
A peer links to its own page where one exists.
Inspire Medical Systems stock FAQ
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $2.07B at the Oct 12, 2026 close of $71.49, with 28.91M shares outstanding. The shares trade on a P/E ratio of 14.7.
What is the Inspire Medical Systems stock forecast?
The consensus analyst 12-month price target for Inspire Medical Systems is $65.00, −9.1% from the last close. Of the 16 firms that rated the stock in the last 90 days, 4 rate it a buy, 9 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
Is Inspire Medical Systems stock overvalued or undervalued?
On Gekko’s estimate Inspire Medical Systems is undervalued: the Oct 12, 2026 close of $71.49 is 22.4% below Gekko Fair Value of $92.11. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Inspire Medical Systems report earnings next?
Inspire Medical Systems is expected to report on Nov 2, 2026, after the market closes (21 days away). Analysts expect earnings of $0.09 per share on revenue of $204.3M. Inspire Medical Systems beat the earnings estimate in 8 of its last 8 reports, moving 13.7% on average across the report.
What is Inspire Medical Systems’s 52-week high and low?
Inspire Medical Systems’s 52-week high is $147.03 and its 52-week low is $38.91; it closed at $71.49 on Oct 12, 2026, −10.8% over the past year. Over the last five years the shares peaked at $330.00 on Jul 14, 2023.
Is Inspire Medical Systems stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Inspire Medical Systems the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.